LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study
Benjamin Musher(Baylor College of Medicine), Angelica Loskog(Uppsala University), Eric K. Rowinsky, Salmaan Jawaid(Baylor College of Medicine), Ann M. Leen(Baylor College of Medicine), Brandon G. Smaglo(The University of Texas MD Anderson Cancer Center), Gustav Ullenhag(Uppsala University), Amanda Brisco(University of South Florida), Linda C. Sandin, Malcolm K. Brenner, Wasif M. Abidi(Baylor College of Medicine), Mohamed O. Othman(Baylor College of Medicine), Meng-Fen Wu(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), James Jing(Baylor College of Medicine), Justyna Leja-Jarblad, Kalpesh Patel(Baylor College of Medicine), Bambi Grilley(Baylor College of Medicine), Emma Eriksson(Uppsala University), Jessica Wenthe(Uppsala University)
Cited by 64
Related Papers
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
|Blood|2003|442
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
|The Journal of Experimental Medicine|2004|390
Medical Complications and Outcomes After Hip Fracture Repair
|Archives of Internal Medicine|2002|374